Researchers from both the CDC and the National Institutes of Health tested 1,868 blood samples of people seeking care for possible Ebola infections. Ebola was confirmed in 1,182 samples, 956 were tested for Plasmodium parasites and 185 came back with positive tests for parasites. The survival rate among patients infected with Ebola sans parasites was 46 percent. Among those with concurrent infections, 58 percent survived. Those with the highest levels of Plasmodium had an 83 percent survival rate.
The study’s authors concluded, “Plasmodium species parasitemia is associated with an increase in the probability of surviving Ebola virus infection. More research is needed to understand the molecular mechanism underlying this remarkable phenomenon and translate it into treatment options for Ebola virus infection.”
More articles on infection control:
Obesity hinders flu vaccine effectiveness
US pediatricians say vaccination rates remain steady, but so do parental concerns
Outlook ‘cautiously optimistic’ in new brain-eating amoeba case
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.